ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Aug 14, 2018 Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

Aug 09, 2018 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information

Aug 07, 2018 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018

Aug 07, 2018 Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors

Aug 06, 2018 Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets

Jun 14, 2018 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call Information

Jun 14, 2018 Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer

Jun 11, 2018 Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15, 2018

May 30, 2018 Elite Pharmaceuticals and SunGen Pharma File ANDA for Extended-Release CNS Stimulant

May 29, 2018 Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA

1 2 3 4 5 6 7 8 9

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.